Howard Lee - 03 Jun 2024 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
03 Jun 2024
Transactions value $
-$24,341
Form type
4
Filing time
05 Jun 2024, 20:10:16 UTC
Previous filing
12 Jun 2023
Next filing
04 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Award $0 +3.08K +2.12% $0.00 148K 03 Jun 2024 Direct F1
transaction AMPH Common Stock Tax liability -$24.3K -579 -0.39% $42.04 148K 05 Jun 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMPH Stock Option (right to buy) Award $0 +6.86K $0.00 6.86K 03 Jun 2024 Common Stock 6.86K $42.25 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares are represented by restricted stock units, or RSUs, all of which vest on June 3, 2025.
F2 The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
F3 All of the shares subject to the option vest on June 3, 2025.